Navigation Links
Lithium profoundly prevents brain damage associated with Parkinson's disease
Date:6/23/2011

Lithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson's disease (PD) in a mouse model of the condition.

Preclinical research is now underway at the Buck Institute for Research on Aging to determine correct dosages for a drug that continues to be the gold standard for the treatment of bipolar disorder. The Buck is currently working toward initiating a Phase IIa clinical studies of lithium in humans in conjunction with standard PD drug therapy. The research appears in the June 24 online edition of the Journal of Neuroscience Research.

"This is the first time lithium has been tested in an animal model of PD," said lead author and Buck Professor Julie Andersen, PhD. "The fact that lithium's safety profile in humans is well understood greatly reduces trial risk and lowers a significant hurdle to getting it into the clinic."

According to Andersen, lithium has recently been suggested to be neuroprotective in relation to several neurodegenerative conditions including Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis and has been touted for its anti-aging properties in simple animals. "We fed our mice levels of lithium that were at the low end of the therapeutic range," said Andersen. "The possibility that lithium could be effective in PD patients at subclinical levels is exciting, because it would avoid many side effects associated at the higher dose range." Overuse of lithium has been linked to hyperthyroidism and kidney toxicity.

PD is a progressive, incurable neurodegenerative disorder that affects 1 million Americans and results in tremor, slowness of movement and rigidity. It is the second most common neurodegenerative disease after Alzheimer's. Between 50,000 and 60,000 new cases are diagnosed each year. Age is the largest risk factor for the PD. Onset usually begins between the ages of 45 and 70 years.

Andersen's research focuses on
'/>"/>

Contact: Kris Rebillot
krebillot@buckinstitute.org
415-209-2080
Buck Institute for Age Research
Source:Eurekalert

Page: 1 2

Related biology news :

1. Uncovering lithiums mode of action
2. Lithium may help radiation target cancer, spare healthy tissue
3. Rising greenhouse gases profoundly impact microscopic marine life
4. Enzyme prevents fatal heart condition associated with athletes
5. New research helps explain how progesterone prevents preterm birth
6. New research helps explain how progesterone preventspreterm birth
7. A protein reinforces memory and prevents forgetfulness
8. Scripps Research scientist discovers natural molecule indirectly prevents stable clot formation
9. Essential oil pill prevents PMS
10. Drug prevents post-traumatic stress syndrome
11. The zebrafishs neural circuit prevents it from biting off more than it can chew
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Scotland votes for independence later this week, its Government ... people that fracking is necessary, research has revealed. , ... tracking public perception of shale gas extraction in the ... living north of the border are the least supportive ... research in the University,s School of Geography, said: "The ...
(Date:9/16/2014)... From the salmon-rich waters of Southeast Alaska to ... Downeast Maine,s lobster, lumber and tourist towns, coastal residents ... about coastal environments divide along political lines. That,s a ... New Hampshire sociologists published this month in the journal ... a lot of environment-related differences from place to place ...
(Date:9/16/2014)... years ago, the Exxon Valdez spilled 11 million gallons ... themselves cleaning up another giant oil spill in the ... study in the Journal of Consumer Research , ... immediate anxieties instead of catalyzing changes in the way ... national news media coverage of these two events helped ...
Breaking Biology News(10 mins):Scottish people most sceptical on fracking, survey shows 2Scottish people most sceptical on fracking, survey shows 3Politics divide coastal residents' views of environment, UNH research finds 2Politics divide coastal residents' views of environment, UNH research finds 3Exxon Valdez 2014: Does media coverage of manmade disasters contribute to consumer complacency? 2
... summer for sports, fans. World records tumbled at the ... 200m world records, knocking tenths of a second off ... the last few decades, which made marathon runner Mark ... increase in population could account for these dramatic improvements. ...
... genetic polymorphisms induce major differentiations in the metabolic ... paper published November 28 in the open-access journal ... of researchers, led by Karsten Suhre, has conducted ... variants in genes involved in the breakdown of ...
... A new and insidious environmental threat has been ... Queen,s and York universities. Along with scientists ... documented biological damage caused by declining levels of ... the phenomenon "aquatic osteoporosis," Queen,s PhD candidate Adam ...
Cached Biology News:100-meter sprint world record could go as low as 9.48 seconds 2Study identifies genetic variants giving rise to differences in metabolism 2Queen's University biologists find new environmental threat in North American lakes 2
(Date:9/16/2014)... N.C. , Sept. 16, 2014 ... heart failure compound has been shown to be effective ... results demonstrate an alternative to intravenous infusions that could ... prodrugs. The data were presented yesterday at the Heart ... Scientific Meeting in Las Vegas . ...
(Date:9/16/2014)... 16, 2014  The Council for Entrepreneurial Development ... in the country, today released a mid-year update ... It showed that in the first ... startups in the technology, life science, advanced ... from a variety of sources. Significant investment in technology ...
(Date:9/16/2014)... September 16, 2014 Convoy Therapeutics, ... and effective products to treat patients directly at ... a proprietary SPACE™ Technology Platform announced today that ... will present at the White Hat Life Science ... Hyatt Regency Phoenix. In addition, interested individuals ...
(Date:9/16/2014)...  Ascendis Pharma A/S, a biotechnology company that ... unmet medical needs, today announced positive interim results ... evaluate once-weekly TransCon Growth Hormone in children with ... results will be presented at the 7th International ... held October 15-18, 2014, in Singapore.  ...
Breaking Biology Technology:Cardioxyl Presents Oral Heart Failure Treatment Data For Its Experimental HNO Prodrug At HFSA 18th Annual Scientific Meeting 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 3CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 4Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 3Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4
... Inc. (Nasdaq: ECTE ), a company developing ... continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep ... from its clinical study of its Symphony tCGM System ... Data from the study confirm that Symphony successfully monitors ...
... create electrical components like resistors, transistors and diodes, that ... Nongjian (NJ) Tao, a researcher at the Biodesign Institute ... molecules may also allow clever designers to produce novel ... conventional electronics. In research appearing in today,s ...
... YORK, Dec. 5, 2011 Levi & Korsinsky is ... securities of Pacific Biosciences of California, Inc. ("PacBio" or ... violations of federal securities laws. For more ... The investigation stems from allegations that the Company failed ...
Cached Biology Technology:Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes 2Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes 3Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes 4S-t-r-e-t-c-h-i-n-g electrical conductance to the limit 2S-t-r-e-t-c-h-i-n-g electrical conductance to the limit 3The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc. 2
... Human Pathogenic Viruses The ... (NCPV) preserves well characterised, authenticated ... secure facility, and NCPV is ... or nucleic acids derived from ...
... and easy to use Ascent ... all members of the Ascent ... a clear and easy-to-follow approach ... user-friendly and highly sophisticated data ...
Roll of Mesh 5m x 25cm...
... The Beacon 2000 Fluorescence Polarization ... basic research and assay development. Standard ... Beacon 2000 System uses a quartz-halogen ... range of 360-700 nm. It accommodates ...
Biology Products: